2,6-Dihydroxy-4-pyrimidinecarboxylic acid; Choline ester
AlkaPlorer ID: AK005012
Synonym: Choline orotate, Cholergol, Rufai B
IUPAC Name: 2,4-dioxo-1H-pyrimidine-6-carboxylic acid
Structure
SMILES: O=C(O)C1=CC(O)=NC(O)=N1
InChI: InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)
InChIKey: PXQPEWDEAKTCGB-UHFFFAOYSA-N
Source
Properties Information
Molecule Weight: 156.097
TPSA?: 103.54
MolLogP?: -0.4140000000000001
Number of H-Donors: 3
Number of H-Acceptors: 5
RingCount: 1
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Potency | 39810.7 | nM | None |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 39810.7 | nM | None |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -6.48 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -4.67 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Peroxisome proliferator-activated receptor gamma | Potency | 39810.7 | nM | None |
| Homo sapiens | Prelamin-A/C | Potency | 1258.9 | nM | None |
| Homo sapiens | Solute carrier family 2, facilitated glucose transporter member 9 | EC50 | 1000000.0 | nM | 10.5281/zenodo.7360607 |
| Leishmania major | Dihydroorotate dehydrogenase (fumarate) | Delta Tm | 0.39 | degrees C | 10.1016/j.ejmech.2018.08.033 |
| Leishmania major | Dihydroorotate dehydrogenase (fumarate) | Delta Tm | 1.29 | degrees C | 10.1016/j.ejmech.2018.08.033 |
| Leishmania major | Dihydroorotate dehydrogenase (fumarate) | Delta Tm | 1.43 | degrees C | 10.1016/j.ejmech.2018.08.033 |
| Leishmania major | Dihydroorotate dehydrogenase (fumarate) | Delta Tm | 1.62 | degrees C | 10.1016/j.ejmech.2018.08.033 |
| Leishmania major | Dihydroorotate dehydrogenase (fumarate) | Delta Tm | 4.32 | degrees C | 10.1016/j.ejmech.2018.08.033 |
| Leishmania major | Dihydroorotate dehydrogenase (fumarate) | Delta Tm | 6.12 | degrees C | 10.1016/j.ejmech.2018.08.033 |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 16944.1 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 19011.5 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 7.726 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 24.21 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -8.58 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.18 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.06 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition index | 0.3534 | None | 10.1101/2020.04.03.023846 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx900326k |
| None | NON-PROTEIN TARGET | Potency | 5.3 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 10583.9 | nM | None |
| None | No relevant target | LogP | -0.83 | None | 10.1016/j.ejmech.2007.05.007 |
| None | Unchecked | Ac50 | 15.85 | uM | None |
| None | Unchecked | AC50 | 15848.9 | nM | None |
| None | Unchecked | Ki | 72210.0 | nM | 10.1016/j.ejmech.2010.09.055 |
